SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-16-723566
Filing Date
2016-09-28
Accepted
2016-09-28 16:16:55
Documents
2
Group Members
CLAIRMARK INVESTMENTS LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13D d270441dsc13d.htm SC 13D 70111
2 EX-99.1 d270441dex991.htm EX-99.1 3133
  Complete submission text file 0001193125-16-723566.txt   74564
Mailing Address C/O ELEVEN BIOTHERAPEUTICS 215 FIRST ST. #400 CAMBRIDGE MA 02142
Business Address
DAN LESLIE (Filed by) CIK: 0001180551 (see all company filings)

Type: SC 13D

Mailing Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142 617-871-9911
Eleven Biotherapeutics, Inc. (Subject) CIK: 0001485003 (see all company filings)

IRS No.: 252025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-87951 | Film No.: 161907121
SIC: 2834 Pharmaceutical Preparations